Choose a signal enzyme as part of the complete immunoassay workflow. The label must participate in target recognition, remain functional through separation or flow, and generate a product that the chosen reader can measure at the required time.
ELISA, CLIA and lateral flow describe overlapping aspects of assay design. Understanding those overlaps makes it easier to compare platforms without assuming that one enzyme or one detection mode will perform best in every format.
Separate the assay format from the signal chemistry
An enzyme-linked immunosorbent assay, or ELISA, uses an enzyme reporter within an immunosorbent assay. A chemiluminescent immunoassay, or CLIA, is identified by its light-emitting readout. A lateral flow assay, or LFA, is identified by transport and capture within a porous flow device. These terms do not define three mutually exclusive enzyme choices.
A solid-phase enzyme immunoassay can use chemiluminescent detection. An enzyme-labelled lateral flow assay can also generate light after substrate addition. Conversely, some CLIA designs use a directly chemiluminescent chemical label rather than an enzyme. Here, CLIA refers to chemiluminescent immunoassay, not the US laboratory regulatory program with the same abbreviation.

Describe a candidate system with three pieces of information: the binding and separation format, the reporter label, and the method used to detect its output. For example, “membrane capture with an HRP reporter and chemiluminescent imaging” is more informative than “a sensitive CLIA.”
The same discipline applies to performance claims. A published detection limit belongs to a particular analyte, antibody system, matrix, protocol and reader. Comparing values from unrelated assays does not establish an inherent ranking of ELISA, CLIA and LFA.
In ELISA, connect retained enzyme to the binding event
In a typical heterogeneous enzyme immunoassay, a solid phase retains material through a target-dependent binding process. Separation or washing reduces unbound reporter before substrate is introduced. The measured response therefore depends on both the amount of enzyme retained and the reaction used to detect it.
The enzyme need not always be attached to the same kind of reagent. In an early competitive assay, Engvall, Jonsson and Perlmann used an enzyme-labelled antigen with antibody-coated tubes. In other architectures, an enzyme-labelled antibody or affinity reagent reports the captured complex. Define that role before selecting a conjugate.
Understand the direction of the response
In a conventional sandwich design, increasing analyte within the working range generally retains more reporter. In a competitive design, analyte can reduce retention of the labelled competitor. A weaker signal therefore has different meanings in the two systems. Keep the raw reporter response distinct from the concentration obtained through calibration.
Evaluate the capture and reporter stages separately when optimizing. An active conjugate cannot compensate for an antibody pair that does not support the intended binding geometry. A strong enzyme reaction also cannot establish that the retained reporter is specific to the target.
Control the separation and substrate stages
Set the washing sequence, residual liquid, substrate volume and development conditions as parts of the method. Compare blanks and low-level samples after changes to any of them. A wash change may alter both nonspecific retention and the amount of target-dependent complex that remains.
For horseradish peroxidase (HRP) and alkaline phosphatase (ALP), substrate selection determines which reporter product is measured. The enzyme-label comparison covers their chemistry. The platform decision adds practical questions about batching, incubation, washing and how consistently development can be started and read across a plate.
In enzyme-based CLIA, coordinate light generation with acquisition
An enzyme-based chemiluminescent assay retains a reporter through its binding architecture and then uses a matched substrate system to generate light. HRP can participate in luminol-family reactions, while ALP can activate suitable phosphate-bearing dioxetanes. Bronstein and colleagues also demonstrated a different dioxetane trigger for beta-galactosidase.
Thorpe and colleagues showed that chemical enhancement could change an HRP-catalysed light reaction. These studies establish possible reporter chemistries; they do not mean that a named enzyme has one fixed emission profile or that any enhanced formulation is suitable for every instrument.
The reader and reagent schedule form one method
Specify how the substrate reaches the captured enzyme, the interval before acquisition and the duration over which light is integrated. In a sequential instrument, samples may be dispensed and read one at a time. In an imaged plate or membrane, several regions may be acquired together. Match the reaction behavior to the actual schedule.
Light collection also depends on geometry and optical isolation. Assess the vessel or membrane, its position relative to the detector and the possibility of signal entering a neighboring measurement region. Use controls that expose those effects rather than attributing every unexpected response to enzyme performance.
Confirm that the label is actually an enzyme
Weeks and colleagues demonstrated an immunoassay using an acridinium ester label. This is an example of direct chemiluminescent labelling. An HRP or ALP substrate selection process does not apply to that label simply because the assay reports light.
Ask for the actual reporter chemistry when transferring a method or comparing platforms. The chemiluminescent enzyme substrate guide explains the enzyme-triggered branch in more detail. Confirm compatibility with the instrument rather than treating relative light units from different readers as a common concentration scale.
In lateral flow, delivery and localization become central
An enzyme-amplified strip must bring together recognition reagents, analyte and substrate in a useful sequence. If the conjugate is dried into the device, it must first rehydrate and release. It then travels through the membrane and participates in capture before the reporter reaction is read.
Specify where unbound reporter goes and when it encounters substrate. If appreciable active enzyme remains outside the intended capture region during development, it can contribute unwanted response. The flow path, washing or clearing step, substrate delivery and absorbent capacity must therefore be developed with the chemistry.

Choose whether to retain a colored product or collect emitted light
A colored line needs adequate spatial contrast at the reading time. A soluble reaction product may move away from its point of formation, while a suitable depositing chemistry can localize visible material. Which option is useful depends on the membrane and assay design; a plate substrate is not automatically a suitable strip substrate.
A chemiluminescent strip requires an optical measurement arrangement. Zangheri and colleagues combined a peroxidase-cortisol competitive assay with added chemiluminescent substrate and a purpose-built smartphone accessory. The study demonstrates that lateral flow and enzyme-generated light can coexist. It also illustrates the need to engineer the optical interface rather than assume that an ordinary phone photograph is equivalent.
Count the user actions as part of the design
Record whether operation requires a timed substrate addition, transfer into a reader, an extra wash or a defined incubation after flow. An additional reaction may improve analytical separation but make the device less suitable for its intended setting. Evaluate handling errors and interpretation variability along with signal.
Storage is another integration question. Demonstrate performance after the conjugate has been dried and stored in the intended package, not only with freshly prepared liquid reagent. The conjugate stability guide distinguishes retained enzyme activity from release and complete-device performance.
Choose the system around operational constraints
| Design dimension | Plate or separated-reaction system | Enzyme-amplified lateral flow system |
|---|---|---|
| Reporter delivery | Controlled pipetting or instrument dispensing into a defined reaction space. | Release, capillary migration and arrival at the capture region must be established. |
| Unbound reporter | Washing or another separation operation is explicitly scheduled. | Movement beyond the test region and any additional clearing step need verification. |
| Development | Substrate mixing, reaction volume and measurement timing are controlled. | Substrate arrival, local reaction conditions and spatial retention require attention. |
| Readout | Selected reader mode, vessel geometry and acquisition settings define measurement. | Visual interpretation or a dedicated optical arrangement must match the signal. |
| Practical use | Assess throughput, reagent access, calibration and instrument workflow. | Assess user steps, environmental exposure, reading window and packaged stability. |
Begin with the setting: available equipment, sample volume, permitted user actions, turnaround needs and target measurement range. Eliminate incompatible designs before comparing fine differences in enzyme performance. This keeps the selection tied to a deliverable assay rather than an isolated bright reaction.
Then compare complete candidate methods using relevant blanks, low-level samples and representative matrices. If each method is optimized separately, report that choice and the associated operating conditions. A comparison that changes the antibody pair, reporter amount and acquisition time together cannot attribute the outcome to the enzyme alone.
When moving an assay between formats, carry forward the biological question and performance requirement, then re-establish delivery, separation and calibration. Document which features transfer and which require new evidence. The immunoassay signal guide collection links the chemistry, stability and interference topics needed to complete that evaluation.
Sources and further reading
- Engvall E, Jonsson K, Perlmann P. Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes. Biochimica et Biophysica Acta. 1971;251:427–434. DOI: 10.1016/0005-2795(71)90132-2.
- Thorpe GH and colleagues. Enhancement of the horseradish peroxidase-catalyzed chemiluminescent oxidation of cyclic diacyl hydrazides by 6-hydroxybenzothiazoles. Analytical Biochemistry. 1985;145:96–100.
- Bronstein I, Edwards B, Voyta JC. 1,2-dioxetanes: novel chemiluminescent enzyme substrates. Applications to immunoassays. Journal of Bioluminescence and Chemiluminescence. 1989;4:99–111. DOI: 10.1002/bio.1170040116.
- Weeks I and colleagues. Acridinium esters as high-specific-activity labels in immunoassay. Clinical Chemistry. 1983;29:1474–1479. DOI: 10.1093/clinchem/29.8.1474.
- Zangheri M and colleagues. A simple and compact smartphone accessory for quantitative chemiluminescence-based lateral flow immunoassay for salivary cortisol detection. Biosensors and Bioelectronics. 2015;64:63–68. DOI: 10.1016/j.bios.2014.08.048.